Actinic Keratosis: Current Therapies and Insights Into New Treatments
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 May 2019
01 May 2019
Historique:
entrez:
30
5
2019
pubmed:
31
5
2019
medline:
23
7
2019
Statut:
ppublish
Résumé
Actinic keratosis (AK) develops on chronically sun-exposed skin and constitutes one of the most common diseases managed by dermatologists. The incidence of AKs continues to rise among aging as well as younger sun damaged populations worldwide, underscoring the importance of effective therapy options. Various treatments are available, including light-based therapies, topical therapies, and destructive therapies. Herein, we review the current management options for AKs and discuss emerging therapeutic agents.
J Drugs Dermatol. 2019;18(5 Suppl 1):s161-166.
Substances chimiques
Dermatologic Agents
0
Imiquimod
P1QW714R7M
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM